Position in CGEM
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$1,352,511
+$461,289 QoQ
Shares Held
74,273
+18.4% QoQ
Ownership
0.115%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#69
of 183 holders
Holding Since
Jun 2024
9 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in CGEM Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Mariner, LLC holds $491,869,472 across 152 Biotechnology names. CGEM ranks #36 (0.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JAZZ |
Jazz Pharmaceuticals plc
|
608,615 | $146,657,956 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
134,614 | $66,866,811 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
|
100,086 | $62,407,624 | |
| 4 | RPRX |
Royalty Pharma plc
|
693,495 | $38,884,263 | |
| 5 | EXEL |
Exelixis, Inc.
|
313,083 | $17,034,845 | |
| 6 | INCY |
Incyte Corp
|
121,988 | $13,828,559 | |
| 7 | BMRN |
Biomarin Pharmaceutical Inc
|
192,607 | $11,020,972 | |
| 8 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
28,021 | $8,435,161 |
All Filings in CGEM
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,352,511 | 74,273 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $891,222 | 62,718 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $508,505 | 49,131 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $166,935 | 28,151 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $124,169 | 16,490 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $92,104 | 12,167 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $425,094 | 34,901 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $259,302 | 15,490 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $285,213 | 16,354 | Shares | Sole | 2024-08-13 | |
| No filing history on record for this holder in this stock. | ||||||